Communicable Diseases

Clarithromycin-loaded Nanoparticles Enhance Antibacterial and Anticancer Performance

Researchers have successfully developed clarithromycin-loaded albumin-based nanoparticles (CLA-BSA NPs) that promise to revolutionize the delivery of antibacterial and anticancer drugs. This innovative drug delivery system, detailed in a study published in Pharmaceutics on May 31, 2025, showcases enhanced therapeutic efficacy for clarithromycin, a widely used antibiotic already known for its diverse medical applications. Clarithromycin (CLA) is a broad-spectrum antibiotic commonly…